A Wealth of New Options: A Case Presentation of the Management of Castration-Recurrent Prostate CancerBEACH, Douglas F; SOMER, Robert A; HOFFMAN-CENSITS, Jean et al.Seminars in oncology. 2012, Vol 39, Num 1, pp 1-8, issn 0093-7754, 8 p.Article

Advances in the Treatment of Metastatic Melanoma: Adoptive T-Cell Therapy : ADVANCED CUTANEOUS MALIGNANCIESBERNATCHEZ, Chantale; RADVANYI, Laszlo G; HWU, Patrick et al.Seminars in oncology. 2012, Vol 39, Num 2, pp 215-226, issn 0093-7754, 12 p.Article

Recent Advances in Pathologic Evaluation and Reporting of Melanoma : ADVANCED CUTANEOUS MALIGNANCIESMATHEW, Rahel; MESSINA, Jane L.Seminars in oncology. 2012, Vol 39, Num 2, pp 184-191, issn 0093-7754, 8 p.Article

Single-Nucleotide Polymorphism Array Karyotyping in Clinical Practice: Where, When, and How? : MOLECULAR PATHOGENESIS OF HEMATOLOGIC MALIGNANCIESSATO-OTSUBO, Aiko; SANADA, Masashi; OGAWA, Seishi et al.Seminars in oncology. 2012, Vol 39, Num 1, pp 13-25, issn 0093-7754, 13 p.Article

Developments in Liver Transplantation for Hepatocellular CarcinomaMELLOUL, Emmanuel; LESURTEL, Mickael; CARR, Brian I et al.Seminars in oncology. 2012, Vol 39, Num 4, pp 510-521, issn 0093-7754, 12 p.Article

Management of Non―Muscle-Invasive (Superficial) Bladder CancerNARGUND, Vinod H; TANABALAN, C. K; KABIR, M. N et al.Seminars in oncology. 2012, Vol 39, Num 5, pp 559-572, issn 0093-7754, 14 p.Article

Innovations in Radical Cystectomy and Pelvic Lymph Node DissectionSTAMATAKIS, Lambros; GODOY, Guilherme; LERNER, Seth P et al.Seminars in oncology. 2012, Vol 39, Num 5, pp 573-582, issn 0093-7754, 10 p.Article

Urachal Adenocarcinoma: A Clinician's Guide for TreatmentSIEFKER-RADTKE, Arlene.Seminars in oncology. 2012, Vol 39, Num 5, pp 619-624, issn 0093-7754, 6 p.Article

An Update on Cancer- and Chemotherapy-Related Cognitive Dysfunction: Current Status : SUPPORTIVE CARE AND PALLIATIVE MEDICINEJANELSINS, Michelle C; KOHLI, Sadhna; MOHILE, Supriya G et al.Seminars in oncology. 2011, Vol 38, Num 3, pp 431-438, issn 0093-7754, 8 p.Article

Best Supportive Care: A Euphemism for No Care or a Standard of Good Care? : SUPPORTIVE CARE AND PALLIATIVE MEDICINECHERNY, Nathan.Seminars in oncology. 2011, Vol 38, Num 3, pp 351-357, issn 0093-7754, 7 p.Article

Hematopoietic Growth Factors in Myelodysplastic SyndromesSTEENSMA, David P.Seminars in oncology. 2011, Vol 38, Num 5, pp 635-647, issn 0093-7754, 13 p.Article

Molecular Biology of Myelodysplastic SyndromesSHIH, Alan H; LEVINE, Ross L.Seminars in oncology. 2011, Vol 38, Num 5, pp 613-620, issn 0093-7754, 8 p.Article

Pharmacologic Management of Cancer-Related Pain, Dyspnea, and Nausea : SUPPORTIVE CARE AND PALLIATIVE MEDICINECHEUNG, Winson Y; ZIMMERMANN, Camilla.Seminars in oncology. 2011, Vol 38, Num 3, pp 450-459, issn 0093-7754, 10 p.Article

Thinking and Talking About Life Expectancy in Incurable Cancer : SUPPORTIVE CARE AND PALLIATIVE MEDICINEKIELY, Belinda E; STOCKLER, Martin R; TATTERSALL, Martin H. N et al.Seminars in oncology. 2011, Vol 38, Num 3, pp 380-385, issn 0093-7754, 6 p.Article

Potential Applications of MicroRNAs in Cancer Diagnosis, Prognosis, and Treatment : MicroRNAs AND CANCER: FROM THE BENCH TO THE CLINICSANDHU, Sukhinder; GARZON, Ramiro.Seminars in oncology. 2011, Vol 38, Num 6, pp 781-787, issn 0093-7754, 7 p.Article

The Role of Single-Photon Emission Computed Tomography and SPECT/Computed Tomography in Oncologic ImagingBRANDON, David; ALAZRAKI, Adina; HALKAR, Raghuveer K et al.Seminars in oncology. 2011, Vol 38, Num 1, pp 87-108, issn 0093-7754, 22 p.Article

Interventional Radiology and Image-Guided Medicine: Interventional OncologySMITH, Kevin A; KIM, Hyun S.Seminars in oncology. 2011, Vol 38, Num 1, pp 151-162, issn 0093-7754, 12 p.Article

Personalized Cancer TreatmentSCHILSKY, Richard L.Seminars in oncology. 2011, Vol 38, Num 2, issn 0093-7754, 163 p.Serial Issue

Pharmacokinetics and Pharmacodynamics of Nilotinib in Gastrointestinal Stromal TumorsTRENT, Jonathan; MOLIMARD, Mathieu.Seminars in oncology. 2011, Vol 38, Num 2, issn 0093-7754, S28-S33, SUP1Article

Clinicopathologic Considerations: How Can We Fine Tune Our Approach to Sarcoma?DEMICCO, Elizabeth G; LAZAF, Alexander J.Seminars in oncology. 2011, Vol 38, Num 5, issn 0093-7754, S3-S18, SUP3Article

Targeted Agents for Sarcoma: Is Individualized Therapy Possible in Such a Diverse Tumor Type?RIEDEL, Richard F.Seminars in oncology. 2011, Vol 38, Num 5, issn 0093-7754, S30-S42, SUP3Article

Gastric Mucosa-Associated Lymphoid Tissue LymphomaMORRIS, Gloria J; DOTAN, Efrat; SMITH, Mitchell R et al.Seminars in oncology. 2010, Vol 37, Num 3, pp 183-187, issn 0093-7754, 5 p.Article

Cancer Prevention With Natural Compounds : Cancer prevention IGULLETT, Norleena P; RUHUL AMIN, A. R. M; BAYRAKTAR, Soley et al.Seminars in oncology. 2010, Vol 37, Num 3, pp 258-281, issn 0093-7754, 24 p.Article

Digitization and Its Discontents: Future Shock in Predictive Oncology : Cancer prediction modelsEPSTEIN, Richard J.Seminars in oncology. 2010, Vol 37, Num 1, pp 60-64, issn 0093-7754, 5 p.Article

Regional Hepatic Chemotherapies in Treatment of Colorectal Cancer Metastases to the Liver : Regional Therapies for Cancers in the LiverAMMORI, John B; KEMENY, Nancy E.Seminars in oncology. 2010, Vol 37, Num 2, pp 139-148, issn 0093-7754, 10 p.Article